CDC Partners with Alveo for Rapid Avian Flu Test Development
The CDC has partnered with Alveo Technologies to develop a rapid, handheld diagnostic test for avian flu in humans, capable of delivering results in 30-45 minutes with accuracy comparable to PCR tests. This initiative addresses the lack of rapid H5N1 testing in the U.S., which currently relies on lab-based tests that can take days or weeks. Alveo's technology aims to decentralize testing, reduce lab bottlenecks, and enhance pandemic preparedness by providing timely detection and intervention capabilities.